Complications of Skull Base Surgery: An Analysis of 30 Cases

被引:12
作者
Sakashita, Tomohiro [1 ]
Oridate, Nobuhiko
Homma, Akihiro
Nakamaru, Yuji
Suzuki, Fumiyuki
Hatakeyama, Hiromitsu
Taki, Shigenari
Sawamura, Yutaka [2 ]
Yamamoto, Yuhei [3 ]
Furuta, Yasushi
Fukuda, Satoshi
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608638, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido 0608638, Japan
来源
SKULL BASE-AN INTERDISCIPLINARY APPROACH | 2009年 / 19卷 / 02期
关键词
Complications; craniofacial resection; skull base surgery; CRANIOFACIAL RESECTION; MALIGNANT-TUMORS; CRANIAL-BASE;
D O I
10.1055/s-0028-1096201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To evaluate the risk factors for perioperative complications among patients undergoing craniofacial resection for the treatment of skull base tumors. Design: Retrospective analysis. Participants: The study group comprised 29 patients with skull base tumors (22 malignant and 7 benign) who underwent 30 craniofacial resections at Hokkaido University Hospital between 1989 and 2006. Of these cases, 21 had undergone prior treatment by radiation (16 cases), surgery (7 cases), or chemotherapy (1 case). Moreover, 19 needed extended resection involving the dura (11 cases), brain (5 cases), orbit (12 cases), hard palate (5 cases), skin (3 cases), or cavernous sinus (2 cases). Main outcome measures: Perioperative complications and risk factor associated with their incidence. Results: Perioperative complications occurred in 12 patients (40%; 13 cases). There was a significant difference between complication rates for cases with and without prior therapy (52.4% vs. 11.1%). The complication rate for dural resection cases was 81.8%. There was a significant difference between complication rates for cases with and without dura resection. No postoperative mortality was reported. Conclusions: Craniofacial resection is a safe and effective treatment for skull base tumors. However, additional care is required in patients with extended resection (especially dural) and those who have undergone prior therapy.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 13 条
[11]   Craniofacial surgery for malignant skull base tumors - Report of an international collaborative study [J].
Patel, SG ;
Singh, B ;
Polluri, A ;
Bridger, PG ;
Cantu, G ;
Cheesman, AD ;
deSa, GM ;
Donald, P ;
Fliss, D ;
Gullane, P ;
Janecka, I ;
Kamata, S ;
Kowalski, LP ;
Kraus, DH ;
Levine, PA ;
dos Santos, LRM ;
Pradhan, S ;
Schramm, V ;
Snyderman, C ;
Wei, WI ;
Shah, JP .
CANCER, 2003, 98 (06) :1179-1187
[12]   Importance of comorbidity in head and neck cancer [J].
Piccirillo, JF .
LARYNGOSCOPE, 2000, 110 (04) :593-602
[13]  
Shah JP, 1997, ARCH OTOLARYNGOL, V123, P1312